Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04141943
Other study ID # 4-2019-0795
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 13, 2020
Est. completion date October 2021

Study information

Verified date November 2020
Source Yonsei University
Contact Yong Bae Kim
Phone +82-2228-8095
Email ybkim3@yuhs.ac
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of providing information about radiotherapy using virtual reality and to see whether it would improve the productivity of medical staff, improve patient experience and satisfaction, and reduce patient's anxiety prior to radiotherapy.


Description:

All patients enrolled in this study will receive the same routine explanation all radiotherapy patients receive currently. However, prior to the routine explanation, additional detailed information regarding radiotherapy (from simulation to treatment) will be given in two different ways. VR arm: The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality. Printed document arm: The patients who are allocated to the Printed document arm will receive information about radiotherapy via printed document. Patients will answer the questionnaire related to the anxiety scale related to radiotherapy and measure the vital signs such as blood pressure, pulse rate, and the respiratory rate. Also, patients will answer the questions about radiotherapy to assess the understanding of radiotherapy and questionnaire on hospital satisfaction.


Recruitment information / eligibility

Status Recruiting
Enrollment 196
Est. completion date October 2021
Est. primary completion date October 2021
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 64 Years
Eligibility Inclusion Criteria: 1. Breast cancer patients who received curative surgery and are planned to receive radiotherapy 2. Patients with cognitive abilities to receive virtual reality information 3. Patients who are 20 years old or older Exclusion Criteria: 1. Patients who have vision or hearing problems to receive information 2. Patients who do not agree to this study 3. Pregnancy, Fetuses / Newborns, Minors, and Deficient Patients 4. 65 years old or older 5. Patients who have been treated for dizziness within the last 6 months 6. Patients who have experienced severe dizziness within the last 6 months when using electronic devices

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual reality
The patients who are allocated to the VR arm will receive information about radiotherapy via virtual reality.

Locations

Country Name City State
Korea, Republic of Severance Hospital Seoul Korea

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amsterdam Preoperative Anxiety and Information Scale (APAIS) Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information
- APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious)
Prior to receiving the radiotherapy information via VR or printed document
Primary Amsterdam Preoperative Anxiety and Information Scale (APAIS) Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information
- APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious)
5 minutes after receiving the radiotherapy information via VR or printed document
Secondary State-Trait Anxiety Inventory (STAI) Changes in STAI Before and After Providing Virtual Reality or Printed Document Information Prior to receiving the radiotherapy information via VR or printed document
Secondary State-Trait Anxiety Inventory (STAI) Changes in STAI Before and After Providing Virtual Reality or Printed Document Information 5 minutes after receiving the radiotherapy information via VR or printed document
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2